Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The cancer cachexia syndrome

M Puccio1, L Nathanson

  • 1Winthrop University Hospital, Mineola, NY, USA.

Seminars in Oncology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Cancer cachexia syndrome causes anorexia and weight loss, unresponsive to caloric intake. Treatments focus on quality of life and may include nutritional counseling and specific medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Range Transverse-Momentum Correlations and Radial Flow in Pb-Pb Collisions at the LHC.

Physical review letters·2026
Same author

Search for Quasiparticle Scattering in the Quark-Gluon Plasma with Jet Splittings in pp and Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2025
Same author

First Measurement of A=4 Hypernuclei and Antihypernuclei at the LHC.

Physical review letters·2025
Same author

Probing Strangeness Hadronization with Event-by-Event Production of Multistrange Hadrons.

Physical review letters·2025
Same author

Measurements of Chemical Potentials in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Observation of Medium-Induced Yield Enhancement and Acoplanarity Broadening of Low-p_{T} Jets from Measurements in pp and Central Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Metabolic Medicine
  • Clinical Nutrition

Background:

  • Cancer cachexia syndrome presents with anorexia, wasting, weight loss, fatigue, and impaired immune function.
  • This complex syndrome results from diminished nutritional intake, altered metabolism, and increased energy expenditure.
  • Tumor and host-derived mediators play a significant role in the etiology of cancer cachexia.

Purpose of the Study:

  • To review the clinical characteristics, etiology, and current treatment strategies for cancer cachexia syndrome.
  • To highlight the importance of improving patient quality of life in managing cachexia.
  • To discuss potential therapeutic agents for managing cancer cachexia.

Main Methods:

  • Literature review of cancer cachexia syndrome.

Related Experiment Videos

  • Analysis of contributing factors including nutritional, metabolic, and inflammatory processes.
  • Evaluation of existing and potential pharmacological interventions.

    • Main Results:

    • Cancer cachexia is characterized by symptoms unresponsive to nutritional support alone.
    • Multiple factors contribute to cachexia, involving complex interactions between the tumor and the host.
    • Current treatments are not fully satisfactory, emphasizing the need for comprehensive management strategies.

    Conclusions:

    • Management of cancer cachexia should prioritize patient quality of life and include nutritional counseling.
    • Treatment considerations must encompass disease-related factors, treatment side effects, and the cachexia syndrome itself.
    • Pharmacological options such as progestogens, corticosteroids, and other agents may offer therapeutic benefits.